Skip to main content
. 2012 Apr 18;2012(4):CD003869. doi: 10.1002/14651858.CD003869.pub3

DeAngelis 1989

Methods RCT: enrolled: not stated evaluated: 58
Participants Inclusion: 1. Histologically confirmed cancer and brain mets (CT) Exclusion: 1. Prior WBRT
Interventions 3000 cGy/10 fr and lonidamide versus 3000 cGy/10 fr
Outcomes 1. Survival 2. Response rates (CR + PR)
Notes QS = 1